Creative Biolabs-Immuno-oncology

Anti-CLEC12A (clone M2E9Q) SynExpress SV-mKa-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR1932)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CLEC12A (clone M2E9Q). We employs the pBR322 (SV40-mKate-IL-10-EcoRI) vector components and the SynExpress system of the Exons Base Editing/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CLEC12A
Clone
M2E9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
SV40
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Base Editing
Modification Domain
Exons
Carrier Type
pBR322
Transformation Accuracy
0.92
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.